Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies

Author:  ["R. Mark Grady","Robert W. Grange","Kim S. Lau","Margaret M. Maimone","Mia C. Nichol","James T. Stull","Joshua R. Sanes"]

Publication:  Nature Cell Biology

CITE.CC academic search helps you expand the influence of your papers.

Tags:  general   CellBiology   CancerResearch   DevelopmentalBiology   StemCells   Biological

Abstract

A dystrophin-containing glycoprotein complex (DGC) links the basal lamina surrounding each muscle fibre to the fibre’s cytoskeleton, providing both structural support and a scaffold for signalling molecules. Mutations in genes encoding several DGC components disrupt the complex and lead to muscular dystrophy. Here we show that mice deficient in α-dystrobrevin, a cytoplasmic protein of the DGC, exhibit skeletal and cardiac myopathies. Analysis of double and triple mutants indicates that α-dystrobrevin acts largely through the DGC. Structural components of the DGC are retained in the absence of α-dystrobrevin, but a DGC-associated signalling protein, nitric oxide synthase, is displaced from the membrane and nitric-oxide-mediated signalling is impaired. These results indicate that both signalling and structural functions of the DGC are required for muscle stability, and implicate α-dystrobrevin in the former.

Cite this article

Grady, R., Grange, R., Lau, K. et al. Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol 1, 215–220 (1999). https://doi.org/10.1038/12034

View full text

>> Full Text:   Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies

Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-κB loop

p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells